INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

Search

Hufvudstaden AB (Class A)

Затворен

119.3 -0.25

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

118.4

Максимум

119.6

Ключови измерители

By Trading Economics

Приходи

-724M

103M

Продажби

-34M

810M

P/E

Средно за сектора

28.966

43.654

EPS

1.18

Дивидентна доходност

2.32

Марж на печалбата

12.752

Служители

248

EBITDA

-224M

187M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.32%

6.00%

Следващи печалби

21.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

607M

24B

Предишно отваряне

119.55

Предишно затваряне

119.3

Hufvudstaden AB (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.08.2025 г., 21:42 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4.08.2025 г., 21:21 ч. UTC

Печалби
Значими двигатели на пазара

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4.08.2025 г., 20:45 ч. UTC

Печалби

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4.08.2025 г., 19:15 ч. UTC

Значими двигатели на пазара

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Nikkei May Rise on Fed Stimulus Hopes

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4.08.2025 г., 21:30 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 21:21 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4.08.2025 г., 21:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 20:25 ч. UTC

Пазарно говорене

India Hits Back Over Russian Oil Purchases -- Market Talk

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss $938M >RIG

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss/Shr $1.06 >RIG

4.08.2025 г., 20:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4.08.2025 г., 20:15 ч. UTC

Печалби

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4.08.2025 г., 20:13 ч. UTC

Печалби

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4.08.2025 г., 20:09 ч. UTC

Печалби

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4.08.2025 г., 20:06 ч. UTC

Печалби

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4.08.2025 г., 19:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

4.08.2025 г., 19:28 ч. UTC

Пазарно говорене

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4.08.2025 г., 19:07 ч. UTC

Пазарно говорене

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4.08.2025 г., 18:27 ч. UTC

Пазарно говорене

Gold Climbs on Rate Cut Speculation -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Hufvudstaden AB (Class A) Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Hufvudstaden AB (Class A)

Hufvudstaden AB (publ) engages in the ownership, development, and management of commercial properties in Stockholm and Gothenburg, Sweden. The company operates through three segments: Property Management, NK Retail, and Other Operations. It offers office and retail properties, residential properties, restaurants, department stores, parking facilities, and shopping centres. The company operates its properties primarily under the NK, Bibliotekstan, Femman, Norrmalmstorg 1, Birger Jarlspassagen, Fredstan, Cecil Coworking, Parkaden, and Nordstan brands. It owns properties with rentable floor spaces. Hufvudstaden AB (publ) was founded in 1915 and is headquartered in Stockholm, Sweden.